Extracellular Lipids in the Lung and Their Role in Pulmonary Fibrosis

被引:25
作者
Burgy, Olivier [1 ,2 ]
Loriod, Sabrina [1 ,2 ]
Beltramo, Guillaume [1 ,2 ,3 ,4 ]
Bonniaud, Philippe [1 ,2 ,3 ,4 ]
机构
[1] Univ Bourgogne Franche Comte, Fac Med & Pharm, INSERM UMR LNC 1231, LabEX LipSTIC, F-21000 Dijon, France
[2] Univ Hosp Dijon Bourgogne, Reference Ctr Rare Lung Dis, F-21000 Dijon, France
[3] Univ Hosp Dijon Bourgogne, Dept Pulm Med, F-21000 Dijon, France
[4] Univ Hosp Dijon Bourgogne, Intens Care Unit, F-21000 Dijon, France
关键词
extracellular lipids; lipid metabolism; idiopathic pulmonary fibrosis; PROSTAGLANDIN E-2 RESISTANCE; LYSOPHOSPHATIDIC ACID; RECEPTOR ANTAGONIST; SPHINGOLIPID METABOLISM; MESENCHYMAL TRANSITION; MOLECULAR-MECHANISMS; THERAPEUTIC TARGETS; CHOLINE TRANSPORTER; CELL-PROLIFERATION; KENNEDY PATHWAY;
D O I
10.3390/cells11071209
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Lipids are major actors and regulators of physiological processes within the lung. Initial research has described their critical role in tissue homeostasis and in orchestrating cellular communication to allow respiration. Over the past decades, a growing body of research has also emphasized how lipids and their metabolism may be altered, contributing to the development and progression of chronic lung diseases such as pulmonary fibrosis. In this review, we first describe the current working model of the mechanisms of lung fibrogenesis before introducing lipids and their cellular metabolism. We then summarize the evidence of altered lipid homeostasis during pulmonary fibrosis, focusing on their extracellular forms. Finally, we highlight how lipid targeting may open avenues to develop therapeutic options for patients with lung fibrosis.
引用
收藏
页数:23
相关论文
共 209 条
  • [91] Differential Regulation of ATP- and UTP-Evoked Prostaglandin E2 and IL-6 Production from Human Airway Epithelial Cells
    Kountz, Timothy S.
    Jairaman, Amit
    Kountz, Candace D.
    Stauderman, Kenneth A.
    Schleimer, Robert P.
    Prakriya, Murali
    [J]. JOURNAL OF IMMUNOLOGY, 2021, 207 (05) : 1275 - 1287
  • [92] Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis
    Kreuter, Michael
    Bonella, Francesco
    Maher, Toby M.
    Costabel, Ulrich
    Spagnolo, Paolo
    Weycker, Derek
    Kirchgaessler, Klaus-Uwe
    Kolb, Martin
    [J]. THORAX, 2017, 72 (02) : 148 - 153
  • [93] A Lipidomics Approach to Identifying Key Lipid Species Involved in VEGF-Inhibitor Mediated Attenuation of Bleomycin-Induced Pulmonary Fibrosis
    Kulkarni, Yogesh M.
    Dutta, Sucharita
    Iyer, Anand Krishnan V.
    Wright, Clayton A.
    Ramesh, Vani
    Kaushik, Vivek
    Semmes, Oliver John
    Azad, Neelam
    [J]. PROTEOMICS CLINICAL APPLICATIONS, 2018, 12 (03)
  • [94] Activated Human Lung Fibroblasts Produce Extracellular Vesicles with Antifibrotic Prostaglandins
    Lacy, Shannon H.
    Woeller, Collynn F.
    Thatcher, Thomas H.
    Pollock, Stephen J.
    Small, Eric M.
    Sime, Patricia J.
    Phipps, Richard P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2019, 60 (03) : 269 - 278
  • [95] Activated human T lymphocytes inhibit TGFβ-induced fibroblast to myofibroblast differentiation via prostaglandins D2 and E2
    Lacy, Shannon H.
    Epa, Amali P.
    Pollock, Stephen J.
    Woeller, Collynn F.
    Thatcher, Thomas H.
    Phipps, Richard P.
    Sime, Patricia J.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2018, 314 (04) : 1569 - 1582
  • [96] Statins: cause of fibrosis or the opposite? Effect of cardiovascular drugs in idiopathic pulmonary fibrosis
    Lambert, Eline M.
    Wuyts, Wim A.
    Yserbyt, Jonas
    De Sadeleer, Laurens J.
    [J]. RESPIRATORY MEDICINE, 2021, 176
  • [97] Idiopathic Pulmonary Fibrosis
    Lederer, David J.
    Martinez, Fernando J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (19) : 1811 - 1823
  • [98] Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo
    Lehmann, Mareike
    Korfei, Martina
    Mutze, Kathrin
    Klee, Stephan
    Skronska-Wasek, Wioletta
    Alsafadi, Hani N.
    Ota, Chiharu
    Costa, Rita
    Schiller, Herbert B.
    Lindner, Michael
    Wagner, Darcy E.
    Guenther, Andreas
    Koenigshoff, Melanie
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (02)
  • [99] Mammalian Ceramide Synthases
    Levy, Michal
    Futerman, Anthony H.
    [J]. IUBMB LIFE, 2010, 62 (05) : 347 - 356
  • [100] Posttreatment with Protectin DX ameliorates bleomycin-induced pulmonary fibrosis and lung dysfunction in mice
    Li, Hui
    Hao, Yu
    Zhang, Huawei
    Ying, Weiyang
    Li, Dan
    Ge, Yahe
    Ying, Binyu
    Cheng, Bihuan
    Lian, Qingquan
    Jin, Shengwei
    [J]. SCIENTIFIC REPORTS, 2017, 7